RxDoctor Payments Data

Kim Stearns, MD

Adult Reconstructive Orthopaedic Surgery · Cleveland, OHNPI 1992764203

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Molnlycke Health Care US, LLC at 58.7% of the total. Reporting peaked in 2022 at $25,480 and has fallen 67.1% since, to $8,379 in 2025.

$80,344in general payments, 2019–2025

Across 230 payments — averaging $349.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Molnlycke Health Care US, LLC$47K
  • Amgen$25K
  • Heron Therapeutics, Inc.$2K
  • Acelrx Pharmaceuticals, Inc.$2K
  • Stryker$2K
  • Forte Bio-pharma LLC$917
  • plus $2K from 10 others

What the payments were for

  • Consulting fees$33,14641%
  • Speaking & faculty fees$25,74032%
  • Travel & lodging$13,85917%
  • Food & beverage$7,5849%
  • Education$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$80,344 in reported general payments places this provider in the 75th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.

See all adult reconstructive orthopaedic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$289,569
Medicare patients
675
Services billed
1,644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Piroxicam416$202,239
Calcipotriene387$134,598
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$39,997
Methocarbamol15$12,833
Meloxicam428$1,187
Celecoxib31$1,081
Etodolac15$520
Diclofenac Sodium13$318
Oxycodone Hcl48$285
Tizanidine Hcl53$168
Amoxicillin86$139
Doxycycline Monohydrate11$114
Methylprednisolone19$102
Tramadol Hcl36$95
Naproxen13$77

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →